BioSpace News Archive

Arcus Biosciences, Inc. announced that the Compensation Committee of the Company’s Board of Directors granted thirteen new employees options to purchase a total of 29,050 shares of the Company’s common stock at an exercise price per share of $27.31, which was the closing price on April 25, 2022, and restricted stock units to acquire a total of 14,525 shares of the Company’s common stock.

Savara Inc., a clinical stage biopharmaceutical company focused on rare respiratory diseases, announced the grant of inducement awards to two new employees.

Aerie Pharmaceuticals, Inc. (NASDAQ: AERI), a pharmaceutical company focused on the discovery, development and commercialization of first-in-class ophthalmic therapies, today announced that fourteen abstracts related to Aerie’s Rhopressa®/netarsudil, AR-15512 in dry eye and “ROCK’Sters” anti-inflammatory programs will be presented at the Association for Research in Vision and Ophthalmology Annual Meeting.

The Medical Device Contract Research Organization Market size is expected to surpass around US$ 15.1 billion by 2030 from valued at US$ 7.3 billion in 2020 with a CAGR of 9.6% from 2021 to 2030.

AtaCor Medical, Inc. (“AtaCor”) announced today that it will present initial findings from its first-in-human extravascular implantable cardioverter defibrillator (EV-ICD) study during the upcoming Stanford Biodesign New Arrhythmia Technologies Retreat.

QIAGEN N.V. announced results for the first quarter of 2022 and increased the outlook for full-year 2022.

Route 92 Medical, Inc., a privately held medical technology company dedicated to improving outcomes for patients undergoing neurovascular intervention, today announced that the U.S. Patent Office (USPTO) has granted the company its 25th U.S. patent for the Monopoint Operating Platform (“Monopoint”), the 40th patent globally.

Galapagos NV announces that theproposed resolutions presented at the extraordinary and annual shareholders’ meetingswere approved, including the implementation of a one-tier governance structure.

Collegium Pharmaceutical, Inc. announced that the Company will host a conference call and live audio webcast on Tuesday, May 10, 2022 at 4:30 p.m. ET.

10x Genomics, Inc., a life sciences leader focused on mastering biology to advance human health, announced the company will be participating in the upcoming BofA Securities 2022 Healthcare Conference in Las Vegas, Nevada.